United States · FDA National Drug Code directory
Abacavir and Lamivudine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42385-962_e6dbfbf4-1917-4764-a6b2-e3da98aa5620
- Product NDC
- 42385-962
- Form
- TABLET, FILM COATED
- Composition / generic term
- Abacavir and Lamivudine
- Labeler
- Laurus Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220725
- Source listing expiry
- 20271231
Source-listed ingredients
- ABACAVIR SULFATE — 600 mg/1
- LAMIVUDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET, FILM COATED in 1 BOTTLE (42385-962-18) · 42385-962-18
- 30 TABLET, FILM COATED in 1 BOTTLE (42385-962-30) · 42385-962-30
- 90 TABLET, FILM COATED in 1 BOTTLE (42385-962-90) · 42385-962-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →